Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

2.11
Delayed Data
As of 3:59pm ET
 +0.02 / +0.96%
Today’s Change
0.80
Today|||52-Week Range
8.96
+74.38%
Year-to-Date
Repros Presents 6-Month Interim Data on Enclomiphene
Aug 16 / Zacks.com - Paid Partner Content
Repros (RPRX) Q2 Loss Narrower Y/Y, Focus on Pipeline
Aug 10 / Zacks.com - Paid Partner Content